Patent · US Active

Anti-PD-1 antibodies and therapeutic uses thereof

US10913797B2 · kind B2 · utility

0Cited by

0References

23Claims

0Family size

Assignee

LYVGEN BIOPHARMA HOLDINGS LIMITED · CN

Inventors

Jieyi Wang · Lake Bluff, US
Liqun Dong · San Diego, US
Yaolin Wang · Short Hills, US

Key dates

Filing date	Nov 17, 2016
Grant date	Feb 9, 2021
Priority date	—
Expiry date	Sep 8, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-PD-1 antibodies and uses thereof in treating diseases associated with the PD-1 signaling, such as cancer, infectious diseases such as viral infection or immune related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.